| Literature DB >> 30828968 |
Maxim Shevtsov1,2,3,4, Stefan Stangl1, Boris Nikolaev5, Ludmila Yakovleva5, Yaroslav Marchenko5, Ruslana Tagaeva5, Wolfgang Sievert1, Emil Pitkin6, Anton Mazur7, Peter Tolstoy7, Oleg Galibin3, Vyacheslav Ryzhov8, Katja Steiger9, Oleg Smirnov8, William Khachatryan4, Kerry Chester10, Gabriele Multhoff1.
Abstract
Functionalized superparamagnetic iron oxide nanoparticles (SPIONs) have emerged as potential clinical tools for cancer theranostics. Membrane-bound 70 kDa heat shock protein (mHsp70) is ubiquitously expressed on the cell membrane of various tumor types but not normal cells and therefore provides a tumor-specific target. The serine protease granzyme B (GrB) that is produced as an effector molecule by activated T and NK cells has been shown to specifically target mHsp70 on tumor cells. Following binding to Hsp70, GrB is rapidly internalized into tumor cells. Herein, it is demonstrated that GrB functionalized SPIONs act as a contrast enhancement agent for magnetic resonance imaging and induce specific tumor cell apoptosis. Combinatorial regimens employing stereotactic radiotherapy and/or magnetic targeting are found to further enhance the therapeutic efficacy of GrB-SPIONs in different tumor mouse models.Entities:
Keywords: glioblastoma; granzyme B; magnetic targeting; radiotherapy; superparamagnetic nanoparticles
Year: 2019 PMID: 30828968 DOI: 10.1002/smll.201900205
Source DB: PubMed Journal: Small ISSN: 1613-6810 Impact factor: 13.281